Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: company in trouble ripe for PTSC to purchase

Axcelis CEO receives 500k a yr too...coincedental I'm sure...but she and BOD turned down a $6.00 offer a share back in the summer when they were in the $5/share range and now...they're 39 cents...plus their BOD had three members who didn't even receive a majority of the votes in May...that tells you what the funds and institutions thought of their leadership...so they resigned...and then what happens????????the rest of the board thought it wasn't in the "shareholders interest" for them to resign..even wiith a majority against them...and you see what that brought the shareholders don't you....Hmm, no thanks...wouldn't touch them with someone elses money thank you...not with that leadership and debt and great decision making for the interest of their shareholders....



BEVERLY, Mass., May 23, 2008 (PRIME NEWSWIRE) -- Axcelis Technologies, Inc. (NasdaqGS:ACLS - News) today reported that the Board of Directors has determined it is not in the best interests of the Company to accept the offers of resignation submitted by the three directors - Stephen R. Hardis, R. John Fletcher and H. Brian Thompson - who were re-elected at the Annual Meeting of Stockholders on May 1, 2008. Because each of the three received less than a majority of the stockholder vote in support of re-election, under Axcelis' corporate governance policies, each was required to offer to resign from the Board. Two separate issues led a majority of the shareholders to withhold authority from the election of the three directors - the failure of the Board to recommend in favor of the declassification proposal and the desire of some shareholders for the Company to engage in discussions with Sumitomo Heavy Industries (``SHI'').

Axcelis stated that after receiving the recommendation of the Nominating and Governance Committee, the Board considered each of the offered resignations and determined not to accept them. Messrs. Hardis, Fletcher and Thompson did not participate in the consideration of the offers of resignation.

In making their determination, the Board considered a number of factors relevant to the best interests of Axcelis. The Board noted that the three directors are experienced and knowledgeable about the Company, and that if their resignations were accepted, the Board would be left with only four remaining directors. One or more of the three directors serves on each of the key committees of the Company and Mr. Hardis serves as lead director. The Board believed that losing this experience and knowledge would harm the Company. The Board also noted that retention of these directors is particularly important if Axcelis is able to move forward on discussions with SHI following finalization of an appropriate non-disclosure agreement

The Board also expressed its intention to be responsive to the shareholder concerns that gave rise to the withhold votes. The Board is seeking to engage in confidential discussions with SHI and, prior to next year's Annual Meeting, the Board will consider recommending in favor of a declassification proposal at that meeting.

Axcelis stated, ``The decision by the Board of Directors assures that Axcelis has the full range of expertise and oversight in place as it proceeds with the business of the Company and potential discussions with SHI. The Board remains committed to serving the long-term business interests of Axcelis and to building the Company's value for all stockholders





Share
New Message
Please login to post a reply